Protagonist Therapeutics
PTGX
47,62 €
Share price
-2.22%
Change (1 day)
32.70%
Change (1 year)
Categories
Operating Margin for Protagonist Therapeutics (PTGX)
Operating Margin as of July 2025 (TTM): 27.47%
According to Protagonist Therapeutics 's latest financial reports and stock price the company's current Operating Margin is 27.47%. At the end of 2024 the company had an Operating Margin of 64.32%.
Operating Margin history for Protagonist Therapeutics from 2018 to 2025
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2024 | 64.32% | -148.88% |
| 2023 | -131.59% | -72.54% |
| 2022 | -479.26% | 4.43% |
| 2021 | -458.94% | 102.61% |
| 2020 | -226.51% | -99.33% |
| 2019 | -33,713.42% | 26146.44% |
| 2018 | -128.45% | -30.27% |
| 2017 | -184.20% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 0.00% | N/A | 🇺🇸 USA |
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.